First Majestic Silver Corp  

(Public, NYSE:AG)   Watch this stock  
Find more results for AG
15.97
-0.20 (-1.24%)
Aug 1 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 15.59 - 16.25
52 week 12.12 - 25.00
Open 16.07
Vol / Avg. 0.00/562,119.00
Mkt cap 1.87B
P/E 16.46
Div/yield     -
EPS 0.97
Shares     -
Beta     -
Inst. own     -

Address

Suite 1805, 925 West Georgia Street
VANCOUVER, BC V6C 3L2
Canada
+1-604-6883033 (Phone)
+1-604-6398873 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

First Majestic Silver Corp. (First Majestic), is engaged in the business of silver production, development, exploration, and acquisition of mineral properties with a focus on silver production in Mexico. The Company has three operating segments located in Mexico, two development projects in Mexico, one retail market segment in Canada and one silver trading segment in Europe. The Company�s operations are within the mining industry and its products are silver dore and lead-silver concentrate. The Company has ownership of three producing mines in Mexico: the La Encantada Silver Mine in Coahuila State, the La Parrilla Silver Mine in Durango State, and the San Martin Silver Mine in Jalisco State. The Company also owns two advanced-stage development silver projects. During the year ended December 31, 2011, the Company acquired a property, Dolores. In July 2012, the Company acquired Silvermex Resources Inc.

Officers and directors

Douglas Penrose Independent Chairman of the Board
Bio & Compensation - Reuters
Keith Neumeyer President, Chief Executive Officer, Director
Bio & Compensation - Reuters
Raymond L. Polman Chief Financial Officer
Bio & Compensation - Reuters
Ramon Davila Chief Operating Officer, Director
Bio & Compensation - Reuters
Martin Palacios Chief Information Officer
Bio & Compensation - Reuters
Connie Lillico Corporate Secretary
Bio & Compensation - Reuters
Robert A. McCallum Independent Director
Bio & Compensation - Reuters
Tony Pezzotti Independent Director
Bio & Compensation - Reuters
David Andrew Shaw Ph.D. Independent Director
Bio & Compensation - Reuters
Robert Young Independent Director
Bio & Compensation - Reuters